Niall C. Tebbutt
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
- Inflammatory Biomarkers in Disease Prognosis 1
- Cancer Cells and Metastasis 1
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Andrew Scott (2 shared papers)Rebecca A. Herbertson (2 shared papers)Andrew Frederick Scarsbrook (1 shared paper)Andrew Richard Norman (1 shared paper)Jaffer A. Ajani (1 shared paper)Mark E. Hill (1 shared paper)David Cunningham (1 shared paper)R. D. Snyder (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Clinical Radiology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Niall C. Tebbutt
13 papers receiving 645 citations
Niall C. Tebbutt's Hit Papers
Peers
Comparison fields: 5 of 46
- Hepatology 265
- Oncology 250
- Cancer Research 65
- Pathology and Forensic Medicine 75
- Pulmonary and Respiratory Medicine 114
Countries citing papers authored by Niall C. Tebbutt
This map shows the geographic impact of Niall C. Tebbutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niall C. Tebbutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niall C. Tebbutt more than expected).
Fields of papers citing papers by Niall C. Tebbutt
This network shows the impact of papers produced by Niall C. Tebbutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niall C. Tebbutt. The network helps show where Niall C. Tebbutt may publish in the future.
Co-authors
The 25 scholars most cited alongside Niall C. Tebbutt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study Hit paper breakdown → | 2020 | 469 |
| 2 | 2008 | 45 | |
| 3 | 2001 | 34 | |
| 4 | 2007 | 23 | |
| 5 | 2017 | 23 | |
| 6 | 1997 | 18 | |
| 7 | 2018 | 14 | |
| 8 | 2012 | 10 | |
| 9 | 2015 | 5 | |
| 10 | 2026 | 5 | |
| 11 | 2016 | 3 | |
| 12 | 2009 | 1 | |
| 13 | 2026 | 1 |
About Niall C. Tebbutt
Niall C. Tebbutt is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 13 papers that have together received 651 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Medical Imaging Techniques and Applications (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Metastasis and carcinoma case studies (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Hepatology (265 citations), Oncology (250 citations), Cancer Research (65 citations), Pathology and Forensic Medicine (75 citations) and Pulmonary and Respiratory Medicine (114 citations). Niall C. Tebbutt has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew Scott, Rebecca A. Herbertson, Andrew Frederick Scarsbrook, Andrew Richard Norman, Jaffer A. Ajani, Mark E. Hill, David Cunningham, R. D. Snyder, W. Ivon Burns and Lara Rachel Lipton. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Radiology, Cancer Chemotherapy and Pharmacology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.